These outcomes, although associative and not causal, align with existing mechanistic and clinical data suggesting that the bioactive constituents of quince, olive leaves and amaranth may modulate key metabolic pathways involved in dyslipidemia, insulin sensitivity, and systemic inflammation. Here, INS is linked to metabolic syndrome.